menu
    • menu

    Company profile for Sairiyo Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Sairiyo is a biotechnology company focused on repurposing and developing improved formulations of naturally derived compounds for serious, rare, and life-threatening diseases with the aim to obtain European Medicines Evaluation Agency and U.S. Food and Drug Administration (“FDA”) approval. Sairiyo is advancing the clinical development of its lead drug candidate, Cepharanthine, a repurposed and reformulated naturally-derive...
    Sairiyo is a biotechnology company focused on repurposing and developing improved formulations of naturally derived compounds for serious, rare, and life-threatening diseases with the aim to obtain European Medicines Evaluation Agency and U.S. Food and Drug Administration (“FDA”) approval. Sairiyo is advancing the clinical development of its lead drug candidate, Cepharanthine, a repurposed and reformulated naturally-derived compound for the potential treatment of cancer, neurological, inflammatory and infectious diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Sairiyo TherapeuticsCanada Flag
    Country
    Country
    Canada
    Address
    Address
    77 King Street West, Suite 2905 Toronto, ON M5K 1H1
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.sairiyothera.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    PharmaTher's Cepharanthine Shows Potential To Bind To Mpox Proteins
    PharmaTher's Cepharanthine Shows Potential To Bind To Mpox Proteins

    21 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/21/2933622/0/en/PharmaTher-s-Sairiyo-Therapeutics-Announces-Independent-Screening-Identifying-Cepharanthine-s-Potential-to-Bind-to-Monkeypox-Mpox-Proteins.html

    GLOBENEWSWIRE
    21 Aug 2024
    Share Share
    PharmaTher's Sairiyo OK'd To Start Phase 1 Trial Of PD-001
    PharmaTher's Sairiyo OK'd To Start Phase 1 Trial Of PD-001

    19 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/19/2932052/0/en/PharmaTher-s-Sairiyo-Therapeutics-Receives-Approval-to-Initiate-a-Phase-1-Human-Clinical-Trial-of-PD-001-Reformulated-Cepharanthine.html

    GLOBENEWSWIRE
    19 Aug 2024
    Share Share
    PharmaTher's Sairiyo Submits CTA For Phase 1 Reformulated Cepharanthine Study
    PharmaTher's Sairiyo Submits CTA For Phase 1 Reformulated Cepharanthine Study

    15 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/15/2882391/0/en/PharmaTher-s-Sairiyo-Therapeutics-Submits-Clinical-Trial-Application-for-Phase-1-Study-of-Patented-Reformulated-Cepharanthine.html

    GLOBENEWSWIRE
    15 May 2024
    Share Share
    PharmaTher's Sairiyo Readies Reformulated Cepharanthine Phase 1
    PharmaTher's Sairiyo Readies Reformulated Cepharanthine Phase 1

    01 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/01/2873176/0/en/PharmaTher-s-Sairiyo-Therapeutics-Completes-Clinical-and-Regulatory-Package-for-Phase-1-Study-of-Patented-Reformulated-Cepharanthine.html

    GLOBENEWSWIRE
    01 May 2024
    Share Share
    Sairiyo Advances Clinical Development of Patented Reformulated Cepharanthine
    Sairiyo Advances Clinical Development of Patented Reformulated Cepharanthine

    21 Feb 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/02/21/2832853/0/en/PharmaTher-s-Sairiyo-Therapeutics-Inc-Advances-Clinical-Development-of-Patented-Reformulated-Cepharanthine-for-Phase-1-Study-in-Australia.html

    GLOBENEWSWIRE
    21 Feb 2024
    Share Share
    PharmaTher Announces Positive Research Results for PharmaPatch™ with N,N-dimethyltryptamine (DMT) and Strategic Investment into Sairiyo Therapeutics
    PharmaTher Announces Positive Research Results for PharmaPatch™ with N,N-dimethyltryptamine (DMT) and Strategic Investment into Sairiyo Therapeutics

    18 Jul 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/07/18/2706302/0/en/PharmaTher-Announces-Positive-Research-Results-for-PharmaPatch-with-N-N-dimethyltryptamine-DMT-and-Strategic-Investment-into-Sairiyo-Therapeutics.html

    GLOBENEWSWIRE
    18 Jul 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search